Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management

Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.

Detalles Bibliográficos
Autores principales: Vélez-Santamaría, Valentina, Nedkova-Hristova, Velina, Morales de la Prida, Moisés, Casasnovas, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789700/
https://www.ncbi.nlm.nih.gov/pubmed/36573111
http://dx.doi.org/10.2147/IJGM.S338430
Descripción
Sumario:Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.

Ejemplares similares